Why the study?
Although an invasive strategy can improve survival in NSTE-ACS, the optimal revascularization treatment between PCI and CABG is not clear.
Does percutaneous coronary intervention compared to coronary artery bypass grafting improve long-term mortality in patients with non-ST-elevation acute coronary syndrome?
Does percutaneous coronary intervention compared to coronary artery bypass grafting improve long-term mortality in patients with non-ST-elevation acute coronary syndrome?
Answers are grounded in this paper and cite their sources.
In patients with NSTE-ACS, PCI and CABG are associated with similar rates of long-term mortality and myocardial infarction, but CABG is associated with lower rates of long-term MACE and re-revascularization.
Non-ST-elevation acute coronary syndrome (NSTE-ACS) affects millions of patients. Although an invasive strategy can improve survival, the optimal treatment [i.e., percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG)] is not clear. We performed a meta-analysis of studies reporting outcomes between PCI and CABG in patients with NSTE-ACS. MEDLINE, EMBASE and Cochrane Library were assessed. The primary outcome was long-term mortality. Inverse variance method and random model were performed. We identified 13 observational studies (48,891 patients). No significant difference was found in the primary endpoint [CABG vs. PCI, incidence rate ratio (IRR) 0.93, 95% confidence interval (CI) 0.70; 1.23]. CABG was associated with lower long-term major adverse cardiovascular events (MACE) (IRR 0.64, 95% CI 0.54; 0.76) and lower long-term re-revascularization (IRR 0.37, 95% CI 0.30; 0.47). There was no significant difference in long-term myocardial infarction (CABG vs. PCI, IRR 0.96, 95% CI 0.50; 1.84) and peri-operative mortality (CABG vs. PCI, odds ratio 1.36, 95% CI 0.94; 1.95). For the treatment of NSTE-ACS, CABG and PCI are associated with similar rates of long-term mortality and myocardial infarction. CABG is associated with lower rates of long-term MACE and re-revascularization. Randomized comparisons in this setting are necessary.
No takes yet. Share an insight, caveat, or question.
Kirov et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: